B. Reed

发表

Glomerular hyperfiltration and renal progression in children with autosomal dominant polycystic kidney disease.

R. Schrier, G. Fick-Brosnahan, K. McFann, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Serum uric acid, kidney volume and progression in autosomal-dominant polycystic kidney disease.

R. Schrier, G. Fick-Brosnahan, K. McFann, 2013, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Identification and characterization of a gene with base substitutions associated with the absorptive hypercalciuria phenotype and low spinal bone density.

B. Reed, W. Gitomer, H. J. Heller, 2002, The Journal of clinical endocrinology and metabolism.

Serum IGF 1 is low and correlated with osteoblastic surface in idiopathic osteoporosis

J. Zerwekh, B. Reed, K. Sakhaee, 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Changing referral characteristics of patients with autosomal dominant polycystic kidney disease.

R. Schrier, K. McFann, I. Helal, 2013, The American journal of medicine.

Diagnostic and Prognostic Biomarkers in Autosomal Dominant Polycystic Kidney Disease

G. Fick-Brosnahan, B. Reed, 2017 .

Angiogenic growth factors correlate with disease severity in young patients with autosomal dominant polycystic kidney disease.

D. Maahs, J. Snell-Bergeon, R. Schrier, 2011, Kidney international.

The effects of chronic administration of T4, growth hormone and epidermal growth factor on hepatic lipogenic enzymes in hypophysectomised rats.

B. Reed, R. Veech, 1986, Biochemical and biophysical research communications.

Mutations in the genomic deoxyribonucleic acid for SLC3A1 in patients with cystinuria.

B. Reed, K. Sakhaee, C. Pak, 1998, The Journal of clinical endocrinology and metabolism.

335‐base deletion in the mRNA coding for a dibasic amino acid transporter‐like protein (SLC3A1) isolated from a patient with cystinuria

B. Reed, C. Pak, W. Gitomer, 1998, Human mutation.

The impact of type II diabetes mellitus in patients with autosomal dominant polycystic kidney disease.

R. Schrier, K. McFann, I. Helal, 2012, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Fluoride‐stimulated [3H] thymidine uptake in a human osteoblastic osteosarcoma cell line is dependent on transforming growth factor β

J. Zerwekh, P. Antich, B. Reed, 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

Evidence for normal vitamin D receptor messenger ribonucleic acid and genotype in absorptive hypercalciuria.

J. Zerwekh, B. Reed, I. Nasonkin, 1995, The Journal of clinical endocrinology and metabolism.

Twenty-four hour growth hormone secretion in a patient with Werner's syndrome

B. Reed, C. Rubin, 1996, Experimental Gerontology.

Treating a Patient with the Werner Syndrome and Osteoporosis Using Recombinant Human Insulin-like Growth Factor

B. Reed, K. Sakhaee, C. Pak, 1994, Annals of Internal Medicine.

Cloning and characterization of the human soluble adenylyl cyclase.

B. Reed, O. Moe, C. Pak, 2005, American journal of physiology. Cell physiology.

The Genetics of Stone Disease

B. Reed, W. Gitomer, 2007 .

Renal ultrasonographic evaluation in children at risk of autosomal dominant polycystic kidney disease.

M. Bekheirnia, R. Schrier, M. Cadnapaphornchai, 2010, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Mapping a gene defect in absorptive hypercalciuria to chromosome 1q23.3-q24.

B. Reed, C. Pak, W. Gitomer, 1999, The Journal of clinical endocrinology and metabolism.

ORIGINAL INVESTIGATIONS Pathogenesis and Treatment of Kidney Disease Presence of De Novo Mutations in Autosomal Dominant Polycystic Kidney Disease Patients Without Family History

Ann M. Johnson, P. Gabow, W. Kimberling, 2008 .

Variation in age at ESRD in autosomal dominant polycystic kidney disease.

Ann M. Johnson, M. Bekheirnia, R. Schrier, 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Genotype-phenotype correlation in X-linked Alport syndrome.

M. Bekheirnia, M. Gregory, R. Schrier, 2010, Journal of the American Society of Nephrology : JASN.

Prevalence of Cardiovascular Events in Patients with Autosomal Dominant Polycystic Kidney Disease

R. Schrier, I. Helal, B. Reed, 2012, American Journal of Nephrology.

Emergent Early Markers of Renal Progression in Autosomal-Dominant Polycystic Kidney Disease Patients: Implications for Prevention and Treatment

R. Schrier, I. Helal, B. Reed, 2012, American Journal of Nephrology.

Modifier genes play a significant role in the phenotypic expression of PKD1.

Ann M. Johnson, P. Fain, R. Schrier, 2005, Kidney international.

Ethanol inhibits some of the early effects of epidermal growth factor in vivo.

M. Gerhart, B. Reed, R. Veech, 1987, Alcoholism, clinical and experimental research.

Angiogenesis and the Pathogenesis of Autosomal Dominant Polycystic Kidney Disease

B. Reed, Wei Wang, 2012 .

Novel Insights on Chronic Kidney Disease , Acute Kidney Injury and Polycystic Kidney Disease

B. Reed, Wei Wang, 2012 .

Prevalence of Cardiovascular Events in Patients with Autosomal Dominant Polycystic Kidney Disease

R. Schrier, I. Helal, B. Reed, 2012, American Journal of Nephrology.

Original Report: Patient-oriented, Translational Research Prevalence of Cardiovascular Events in Patients with Autosomal Dominant Polycystic Kidney Disease

B. Reed, Imed Helal, Pamela Mettler Kim, 2022 .

Circulating angiopoietin-1 could be confounded by ex vivo platelet activation.

R. Schrier, B. Reed, 2011, Kidney International.